Log In
Print this Print this

MammaPrint FFPE

  Manage Alerts
Collapse Summary General Information
Company Agendia N.V.
DescriptionBreast cancer prognostic test using a 70-gene signature chip
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationBreast cancer
Indication DetailsPredict the risk of breast cancer recurrence
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today